Outrage over high drug costs unlikely to bring change any time soon By: MarketWatch September 23, 2015 at 13:06 PM EDT The debate about drug-price inflation may lead to fund flight out of biotech-focused mutual funds and ETFS. Read More >> Related Stocks: Gilead Sciences S&P Biotech SPDR Valeant Pharmaceuticals International, Inc.